A detailed history of Midland Wealth Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Midland Wealth Advisors LLC holds 3,267 shares of LLY stock, worth $2.63 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
3,267
Previous 3,756 13.02%
Holding current value
$2.63 Million
Previous $3.4 Billion 14.89%
% of portfolio
0.17%
Previous 0.2%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$772.14 - $960.02 $377,576 - $469,449
-489 Reduced 13.02%
3,267 $2.89 Billion
Q2 2024

Aug 01, 2024

SELL
$724.87 - $909.04 $18,846 - $23,635
-26 Reduced 0.69%
3,756 $3.4 Billion
Q1 2024

May 13, 2024

SELL
$592.2 - $792.28 $238,656 - $319,288
-403 Reduced 9.63%
3,782 $2.94 Billion
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $2.2 Million - $2.59 Million
4,185 New
4,185 $2.44 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $766B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Midland Wealth Advisors LLC Portfolio

Follow Midland Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Midland Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Midland Wealth Advisors LLC with notifications on news.